Lively and in-depth discussions of city news, politics, science, entertainment, the arts, and more.
Hosted by Larry Mantle
Airs Weekdays 10 a.m.-12 p.m.

Homeopathy practitioners defend safety claims at FDA hearings




Staff at Ainsworth Pharmacy make up homeopathic remedies on August 26, 2005 in London. British medical journal The Lancet has attacked the use of homeopathic treatments saying that doctors should be honest about homeopathy's lack of benefit.
Staff at Ainsworth Pharmacy make up homeopathic remedies on August 26, 2005 in London. British medical journal The Lancet has attacked the use of homeopathic treatments saying that doctors should be honest about homeopathy's lack of benefit.
Peter Macdiarmid/Getty Images

Listen to story

14:29
Download this story 6.0MB

The U.S. Food and Drug Administration is in the midst of hearings to assess how to regulate homeopathic medicine and practice for the first time in a quarter-century.  

More than half a dozen proponents of homeopathy - which is based on the belief that disease symptoms can be cured by minute doses of a remedy that would, in larger amounts, produce in healthy persons symptoms similar to the disease - are testifying before the FDA, along with skeptics who think such remedies should be subjected to the same scrutiny as over-the-counter drugs.

Would that mean homeopathy would be subjected to clinical trials? How should labeling change? Is enough known about the side effects of homeopathic products?

Guests:

Michael De Dora, director of the Center for Inquiry's Office of Public Policy; a non-profit organization advocating for science-based policy; De Dora provided testimony to the FDA hearings on homeopathy oversight

Paul Herscu, ND & MPH, Licensed Naturopathic Physician and published author who writes frequently on issues in homeopathy